You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 5, May 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Quality of Care, Other
 •Neoplasms
 •Diagnosis
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

How Melanoma Is Treated in Real Life

Reinhard Dummer, MD; Dirk Schadendorf, MD

Arch Dermatol. 2008;144(5):664-665.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Melanoma still is the major problem of dermato-oncology. Its continuously rising incidence rate over decades has also been accompanied by an unchanged proportion of thicker melanomas associated with an increased mortality, especially in the male population.1 So far, public prevention campaigns have failed to stop this development in most countries. Many new technical devices have been evaluated to increase the specificity of initial diagnosis.

Dermatologists are responsible for organizing medical care for patients with melanoma and for arranging diagnostic and therapeutic procedures if they do not perform them themselves. In many countries worldwide, consensus guidelines for the medical care of patients with melanoma have been established.2-3 However, little is known about the translation of these recommendations into the daily clinical practice of treating patients with melanoma, especially outside of university settings.

The French working group led by Grange et al4-5 should be congratulated for . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Variations in Management of Stage I to Stage III Cutaneous Melanoma: A Population-Based Study of Clinical Practices in France
Florent Grange, Fabien Vitry, Florence Granel-Brocard, Dan Lipsker, Francois Aubin, Guy Hédelin, Sophie Dalac, François Truchetet, Catherine Michel, Marie-Laure Batard, Béatrice Baury, Jean-Michel Halna, Jean Luc Schmutz, Christian Delvincourt, Georges Reuter, Stéphane Dalle, Phillipe Bernard, and Arlette Danzon
Arch Dermatol. 2008;144(5):629-636.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.